“One of the most exciting fields in all of biomedical research right now is oncoimmunology,” writes Mark Wanner of The Jackson Laboratory (JAX). “The premise has been around for decades, and on the surface it is simple: Get a cancer patient’s immune system to recognize cancer cells as foreign, as they do a virus or bacterium, and mount a response to kill them.”

Wanner reports that JAX Professor A. Karolina Palucka and co-author Lisa Coussens document in a review paper in Cell that much work remains to make the treatments more precise and more effective.